Back
Direxion Daily MSCI Emerging Markets Bull 3x Shs Vs. Akero Therapeutics, Inc. Industry Stock Comparison
Buy
64
EDC
Direxion Daily MSCI Emerging Markets Bull 3x Shs
Last Price:
$52.59
Seasonality Move:
4.55%
Buy
55
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.65
Seasonality Move:
1.27%
Buy
64
Direxion Daily MSCI Emerging Markets Bull 3x Shs (EDC)
is a Buy
Is Direxion Daily MSCI Emerging Markets Bull 3x Shs a Buy, Sell or Hold?
-
The current Direxion Daily MSCI Emerging Markets Bull 3x Shs [EDC] share price is $51.89. The Score for EDC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
EDC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDC Stock Price Chart
What is Direxion Daily MSCI Emerging Markets Bull 3x Shs's stock price today?
-
The Direxion Daily MSCI Emerging Markets Bull 3x Shs share price today is $51.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDC is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics, Inc.'s stock price today?
-
The Akero Therapeutics, Inc. share price today is $54.65The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
EDC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 50.62 | Buy |
| Chaikin Money Flow: | 3000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.92 - 52.82) | Buy |
| Bollinger Bands (100): | (44.41 - 54.27) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.32 - 54.64) | Buy |
| Bollinger Bands (100): | (46.63 - 54.53) | Buy |
EDC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.3 | Buy |
| 20-day SMA: | 51.37 | Buy |
| 50-day SMA: | 52.63 | Sell |
| 200-day SMA: | 41.68 | Buy |
| 8-day EMA: | 51.06 | Buy |
| 20-day EMA: | 51.56 | Buy |
| 50-day EMA: | 51.47 | Buy |
| 200-day EMA: | 44.3 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.65 | Sell |
| 20-day SMA: | 54.53 | Buy |
| 50-day SMA: | 54.21 | Buy |
| 200-day SMA: | 48.49 | Buy |
| 8-day EMA: | 54.63 | Buy |
| 20-day EMA: | 54.48 | Buy |
| 50-day EMA: | 53.37 | Buy |
| 200-day EMA: | 48.02 | Buy |
Direxion Daily MSCI Emerging Markets Bull 3x Shs Earnings Growth & EDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics, Inc. Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.
Direxion Daily MSCI Emerging Markets Bull 3x Shs Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||